Inovio Pharmaceuticals Inc
INO
Market Cap$283.98M
Close$
$-1.43
114.7% downside
Current Fair Value
114.7% downsideOvervalued by 114.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $283.98 Million |
|---|---|
| Enterprise Value | $178.37 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-5.53 |
| Beta | 1.59 |
| Outstanding Shares | 25,910,701 |
| Avg 30 Day Volume | 316,404 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -2.27 |
|---|---|
| PEG | 9.08 |
| Price to Sales | - |
| Price to Book Ratio | 3.26 |
| Enterprise Value to Revenue | 248.74 |
| Enterprise Value to EBIT | -1.47 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Inovio Pharmaceuticals Inc
CEO: Jong Kim